1. Home
  2. CTNM vs ETD Comparison

CTNM vs ETD Comparison

Compare CTNM & ETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

SELL

Current Price

$9.57

Market Cap

550.7M

Sector

N/A

ML Signal

SELL

Logo Ethan Allen Interiors Inc.

ETD

Ethan Allen Interiors Inc.

SELL

Current Price

$16.89

Market Cap

569.7M

ML Signal

SELL

Company Overview

Basic Information
Metric
CTNM
ETD
Founded
2009
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
550.7M
569.7M
IPO Year
2024
1996

Fundamental Metrics

Financial Performance
Metric
CTNM
ETD
Price
$9.57
$16.89
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $21.43
N/A
AVG Volume (30 Days)
★ 596.9K
577.6K
Earning Date
11-03-2026
11-09-2026
Dividend Yield
N/A
★ 27.49%
EPS Growth
★ 0.46
N/A
EPS
N/A
★ 0.07
Revenue
N/A
★ $766,784,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.87
P/E Ratio
★ N/A
$250.43
Revenue Growth
N/A
★ N/A
52 Week Low
$6.73
$17.34
52 Week High
$17.79
$25.26

Technical Indicators

Market Signals
Indicator
CTNM
ETD
Relative Strength Index (RSI) 46.25 30.80
Support Level $8.59 N/A
Resistance Level $13.72 $23.11
Average True Range (ATR) 0.77 0.76
MACD 0.23 -0.33
Stochastic Oscillator 42.33 0.40

Price Performance

Historical Comparison
CTNM
ETD

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

Share on Social Networks: